DxNA
FDA Clears DxNA's Valley Fever Molecular Test
The test runs on the GeneSTAT system, and has demonstrated 100 percent sensitivity, 99.6 percent specificity, and 100 percent reproducibility.
DxNA Signs Middle East Food Testing Deal for MDx System
The distribution deal covers the GeneStat system and associated food testing products, including an upcoming pork DNA detection assay.
DxNA Files for FDA Clearance of MDx System, Valley Fever Assay
The firm's real-time PCR-based GeneStat system was developed leveraging IP licensed exclusively from the Translational Genomics Research Institute.
NEW YORK (GenomeWeb) — The Translational Genomics Research Institute and Northern Arizona University have been jointly awarded a US patent for an allele-specific, real-time PCR-based assay to detect H1N1 pandemic flu and resistance to antiviral treatments.
DxNA Receives $2.5M Equity Investment
NEW YORK (GenomeWeb News) – Molecular diagnostics company DxNA has received a $2.5M equity investment from an unnamed individual investor.
Jul 18, 2013
May 9, 2013
May 2, 2012
May 13, 2010
Dec 17, 2009
Dec 14, 2009